Literature DB >> 9642670

The effect of glutamate and inhibitors of NMDA receptors on postdenervation decrease of membrane potential in rat diaphragm.

A Kh Urazaev1, N V Naumenko, G I Poletayev, E E Nikolsky, F Vyskocil.   

Abstract

The early postdenervation depolarization of rat diaphragm muscle fibers (8-10 mV within 3 h in vitro) is substantially smaller (3 mV) when muscles are bathed with 1 x 10(-3) M L-glutamate (Glu) or 1 x 10(-3) M N-methyl-D-aspartate (NMDA). The effects of Glu and NMDA are inhibited in a dose-dependent manner by competitive inhibitor 2-amino-5-phosphonovaleric acid (APV) with Ki 6.3 x 10(-4) M, by 2 x 10(-7) M MK-801, which acts as an open channel inhibitor, by 2-3 x 10(-4) Zn2+, which reacts with surface-located sites of the NMDA subtype of the glutamate receptor, and also by glycine-free solutions and 7-Cl-kynurenic acid, which inhibits the glycine binding sites on NMDA receptors. It follows that the effect of glutamate on early post-denervation depolarization is mediated by the NMDA subtype of glutamate receptor with similar pharmacological properties to those found in neurons. The only exception found was the glutamate-like action of 1 x 10(-7) M MK-801, which partially prevented the early postdenervation depolarization when present in the muscle bath during the first 3 h after nerve section.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642670     DOI: 10.1007/bf02815179

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  2 in total

1.  The effects of glutamate on spontaneous acetylcholine secretion processes in the rat neuromuscular synapse.

Authors:  A I Malomuzh; M R Mukhtarov; A Kh Urazaev; E E Nikol'skii; F Vyskochil
Journal:  Neurosci Behav Physiol       Date:  2002 Nov-Dec

Review 2.  Early postdenervation depolarization is controlled by acetylcholine and glutamate via nitric oxide regulation of the chloride transporter.

Authors:  Frantisek Vyskocil
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.